Merck & Co. Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital decreased by 28.6% to $1.61B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 56.5%, from $3.71B to $1.61B. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive value indicates cash generation through efficient working capital management, while a negative value indicates cash tied up in operations.
This metric aggregates changes in working capital components, such as accounts receivable, inventory, and accounts payab...
Highly comparable across all sectors; a key indicator of operational efficiency and cash conversion cycle health.
operating_increase_decrease_in_operating_capital| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.46B | $139.00M | $1.30B | $1.40B | $2.89B | $1.64B | $3.38B | $1.01B | $3.71B | $2.26B | $1.61B |
| QoQ Change | — | -90.5% | +834.5% | +7.7% | +106.6% | -43.4% | +106.7% | -70.1% | +266.8% | -39.1% | -28.6% |
| YoY Change | — | — | — | -4.4% | +122.5% | +16.9% | +17.0% | -38.1% | +9.8% | +123.2% | -56.5% |